Clear Street’s Protagenic Therapeutics Warrant PTIXW Stock Holding History

Clear Street’s Portfolio PTIXW Stock Details PTIXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$2.39K	–	1153
2025 Q4	$2.39K	Hold	100,000	–	–	﹤0.01%	845
2025 Q3	$2.56K	Hold	100,000	–	–	﹤0.01%	746
2025 Q2	$4.77K	Hold	100,000	–	–	﹤0.01%	554
2025 Q1	$750	Buy	+100,000	New	+$510	﹤0.01%	502

Clear Street's PTIXW Position: Q1 2026 in Review

Clear Street sold out of Protagenic Therapeutics Warrant (PTIXW) in Q1 2026, closing a stake of 100,000 shares — an estimated $2.39K sold.

Clear Street first reported a position in PTIXW in Q1 2025 and held it in 4 quarters. The position peaked at $4.77K in Q2 2025. 0 funds tracked by Wall St. Rank hold PTIXW as of Q1 2026.

Clear Street reported no remaining Protagenic Therapeutics Warrant position as of Q1 2026 after selling out during the quarter.
Clear Street sold 100,000 Protagenic Therapeutics Warrant shares in Q1 2026, an estimated $2.39K.
Clear Street first reported a position in Protagenic Therapeutics Warrant in Q1 2025 and held it in 4 quarters.
Clear Street's Protagenic Therapeutics Warrant position peaked at $4.77K in Q2 2025.
0 funds tracked by Wall St. Rank held Protagenic Therapeutics Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.